Cosmos Health Inc.

About Cosmos Health Inc.

Cosmos Health Inc. is an international healthcare group based in Chicago, Illinois, incorporated in 2009. The company is committed to serving human healthcare needs with passion and humanity. It operates in the nutraceuticals and pharmaceutical sectors, focusing on proprietary product lines, branded generics, over-the-counter (OTC) medications, and healthcare distribution through subsidiaries in the EU and UK. Additionally, it emphasizes research and development (R&D) of novel patented nutraceuticals, specialized root extracts, complex generics, and innovative OTC products.

Products & Services

Sky Premium Life:A line of high-quality nutritional supplements made with carefully selected raw materials, adhering to strict pharmaceutical standards and GMP protocols, designed to support modern lifestyle needs.

Mediterranation:A product line inspired by Mediterranean nature, focusing on health and wellness products that reflect the region's natural essence.

Branded Generics and OTC Medications:A broad range of pharmaceutical products provided to meet various healthcare needs.

Healthcare Distribution:Services provided through subsidiaries in the EU and UK, catering to retail pharmacies and wholesale distributors.

Sky Premium Life

Mediterranation

Specialties

Nutraceuticals Pharmaceuticals Healthcare Distribution Research and Development of Patented Nutraceuticals Specialized Root Extracts Complex Generics Innovative OTC Products Nutraceuticals R&D Branded generics OTC medications Healthcare distribution

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Venture Debt T: - FT: Venture Debt	A: 25000000 MR: - FA: 25000000 FAN: 25000000	D: 2026-06-02 FD: 2026-06-02	1 investors
2	RT: Venture Debt T: - FT: Venture Debt	A: 29000000 MR: - FA: €25 million FAN: 29000000	D: 2026-05-14 FD: 2026-05-14	1 investors
3	RT: Debt T: - FT: Debt	A: 300000000 MR: - FA: up to $300 million FAN: 300000000	D: 2025-08-06 FD: 2025-08-06	1 investors
4	RT: Debt T: - FT: Debt	A: 2293830 MR: - FA: €2,200,000 FAN: 2293830	D: 2025-01-28 FD: 2025-01-28	1 investors

Venture Debt Latest

2026-06-02

$25.0M

1 investor (Pro only)

Venture Debt 2026-05-14

$29.0M

Debt 2025-08-06

$300.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

Greg Siokas

Chief Executive Officer

T

Theodoros C. Karkantzos

Independent Director (M&A)

D

Demetrios Demetriadis

Independent Member

A

Anastasios Aslidis

Independent Director & Audit Committee

J

John Hoidas

Independent Member

S

Suhel Bhutawala

Director

View 10 more team members with Pro

Unlock Full Team Directory

Recent News